Spots Global Cancer Trial Database for progesterone receptor positive tumor
Every month we try and update this database with for progesterone receptor positive tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer | NCT01385280 | Estrogen Recept... Progesterone Re... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | therapeutic est... exemestane laboratory biom... enzyme-linked i... | - | University of Arizona | |
| A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) | NCT02000375 | Metastatic Brea... Estrogen Recept... Estrogen Recept... Progesterone Re... Progesterone Re... Androgen Recept... | DHEA | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer | NCT01385280 | Estrogen Recept... Progesterone Re... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | therapeutic est... exemestane laboratory biom... enzyme-linked i... | - | University of Arizona | |
| A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) | NCT02000375 | Metastatic Brea... Estrogen Recept... Estrogen Recept... Progesterone Re... Progesterone Re... Androgen Recept... | DHEA | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer | NCT04086875 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Estrogen Recept... Progesterone Re... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... | Focus Group Text Message Best Practice Questionnaire A... | 18 Years - | Thomas Jefferson University | |
| Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression | NCT03870399 | Neuroendocrine ... Progesterone Re... Estrogen Recept... | Tamoxifen | 18 Years - | AC Camargo Cancer Center | |
| Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer | NCT01385280 | Estrogen Recept... Progesterone Re... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | therapeutic est... exemestane laboratory biom... enzyme-linked i... | - | University of Arizona | |
| Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression | NCT03870399 | Neuroendocrine ... Progesterone Re... Estrogen Recept... | Tamoxifen | 18 Years - | AC Camargo Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
